BioSpace News Archive

Deals

Sartorius Stedim Biotech closes acquisition of BIA Separations

Sartorius Stedim Biotech, a leading partner of the biopharma industry, successfully closed the acquisition of the Slovenian purification specialist BIA Separations.

November 2, 2020
·
3 min read
BioMidwest

Alzheimer’s Association and CVS Health Join Together To Fight Alzheimer’s for Second Consecutive Year

November in-store fundraising campaign to support Alzheimer’s Association’s efforts to help those at greater risk of COVID-19

November 2, 2020
·
3 min read
Pharm Country

Physicians’ Education Resource® Educates on Cutting-Edge Cancer Breakthroughs and Treatments at the 38th Annual Chemotherapy Foundation Symposium

Three-day virtual conference features over 100 internationally renowned faculty discussing latest clinical insights and data for the future of cancer care.

November 2, 2020
·
3 min read
BioCapital

Dialysis Patient Citizens and Consumers’ Checkbook Introduce Dialysis Plan Choice To Help Patients During Open Enrollment

Dialysis Patient Citizens introduced Dialysis Plan Choice, a new online tool designed in collaboration with Consumers’ Checkbook for dialysis patients to quickly and easily compare their current Medicare Fee-For-Service plan with the options available to them through Medicare Advantage now that Open Enrollment is underway.

November 2, 2020
·
2 min read
Biotech Beach

Pancreatic Cancer Action Network (PanCAN) Launches 30 Stories Over 30 Days Starting With Patrick Swayze’s Widow, Lisa Niemi Swayze, In Time For November’s Pancreatic Cancer Awareness Month

Alex Trebek’s Brave Battle and The Recent Passing of Supreme Court Justice Ruth Bader Ginsburg and Rep. John Lewis, Lead to Increased Public Awareness of Pancreatic Cancer

November 2, 2020
·
3 min read
Deals

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Nov 02, 2020

Paratek Pharmaceuticals, Inc. announced that on October 30, 2020, the Company granted stock options and restricted stock units to two new employees of the Company.

November 2, 2020
·
3 min read
Drug Development

Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE and its Off-the-Shelf Neoantigen Immunotherapy SLATE

Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that it has begun dosing patients in the Phase 2 expansion cohorts of the Phase 1/2 clinical studies for GRANITE and SLATE, its neoantigen-based immunotherapies.

November 2, 2020
·
6 min read
BioCapital

Immunomic Therapeutics to Present at The Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting & Pre-Conference Programs

Immunomic Therapeutics, Inc. will present preclinical data on its investigational nucleic acid platform, UNITE (UNiversal Intracellular Targeted Expression), that elicits potent immune responses when used with its investigational UNITE vaccine, ITI-3000, in mice.

November 2, 2020
·
4 min read
PolarityTE Announces Successful Completion of Initial Pre-IND Interaction with U.S. Food and Drug Administration for SkinTE®

PolarityTE, Inc. (Nasdaq: PTE) announced that it recently received written responses from FDA following a Type B Pre-IND meeting request that the Company submitted in August 2020 regarding an indication for SkinTE to treat diabetic foot ulcers (DFUs)

November 2, 2020
·
6 min read
Business

VBI Vaccines Announces Third Quarter 2020 Financial Results and Provides Corporate Update

BLA and MAA on-track for Q4 submission for regulatory approval of Sci-B-Vac ® in the U.S. and Europe Secured contributions from the Canadian Government (up to CAD$56 million) and the National Research Council of Canada (up to CAD$1 million) for development and scale-up manufacturing of coronavirus program Initial adaptive Phase 1/2 clinical study of coronavirus vaccine program expected to begin around year-end 2020

November 2, 2020
·
13 min read